What are the signs and symptoms of Brugada Syndrome?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 11, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Signs and Symptoms of Brugada Syndrome

Brugada syndrome is characterized by distinctive ECG abnormalities and increased vulnerability to ventricular fibrillation and sudden cardiac death, occurring in the absence of structural heart disease. 1

Key Clinical Manifestations

Symptoms

  • Syncope: Often the first presenting symptom, particularly in young to middle-aged adults 1
  • Cardiac arrest: May occur without warning, especially during sleep or rest 1, 2
  • Palpitations: May precede syncopal episodes 1
  • Nocturnal agonal respiration: Breathing difficulties during sleep 2

Timing and Triggers

  • Sleep-related events: Cardiac events predominantly occur during sleep or rest 1, 2
  • Fever-induced episodes: Fever can acutely trigger cardiac arrest or unmask the ECG pattern 1
  • Vagal stimulation: Increased vagal tone or withdrawal of sympathetic activity may precipitate arrhythmias 1

Electrocardiographic Features

Diagnostic ECG Patterns

  • Type 1 Brugada pattern (diagnostic): Coved ST-segment elevation ≥2mm followed by a negative T-wave in right precordial leads (V1-V3) 1
  • Type 2 Brugada pattern: "Saddleback" morphology with high takeoff ST-segment elevation, remaining ≥1mm above baseline, followed by a biphasic or positive T-wave 1
  • Type 3 Brugada pattern: Either coved or saddleback morphology with J-point elevation ≥2mm but terminal portion of ST-segment <1mm 1

Additional ECG Findings

  • Intermittent pattern: ECG changes may be transient and dynamic 1, 3
  • S1, S2, S3 pattern: May mimic left anterior hemiblock 1
  • Conduction abnormalities: Prolonged PR interval (>200ms) and QRS prolongation in V2 (≥120ms) 3
  • Fragmented QRS complexes: Associated with increased arrhythmic risk 3

Demographics and Risk Factors

  • Male predominance: >90% of clinically affected individuals are male 1, 2
  • Age of presentation: Typically third and fourth decades of life 1
  • Genetic factors: Autosomal dominant inheritance pattern, with SCN5A mutations accounting for 15-30% of cases 1, 4
  • Geographic distribution: Higher prevalence in Southeast Asian populations 2

Important Clinical Considerations

Risk Stratification

  • Spontaneous Type 1 ECG pattern carries higher risk than drug-induced pattern 1
  • History of syncope with spontaneous Type 1 ECG indicates 6-fold higher risk of cardiac arrest 1
  • Asymptomatic individuals with characteristic ECG may still be at risk, regardless of family history 1

Diagnostic Challenges

  • ECG changes can be intermittent and may require provocative testing with sodium channel blockers 1, 3
  • Modified lead placement (V1-V2 in 2nd or 3rd intercostal space) may improve detection 1
  • Fever, electrolyte disturbances, and increased vagal tone can enhance ST-segment elevation 1

Differential Diagnosis

  • Early repolarization patterns in athletes (upsloping ST-segment with STJ/ST80 ratio <1) 1
  • Brugada phenocopy: similar ECG pattern due to other conditions (e.g., pneumopericardium, pericarditis) 5
  • Incomplete right bundle branch block 3

Recognizing these signs and symptoms is crucial for early diagnosis and management of Brugada syndrome to prevent sudden cardiac death, particularly in young adults with no apparent structural heart disease.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Brugada Syndrome.

JACC. Clinical electrophysiology, 2022

Research

[Brugada ECG].

Herzschrittmachertherapie & Elektrophysiologie, 2015

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.